Molecular Devices products to be supplied and serviced by Bio-Strategy
After 1 June, Molecular Devices products (previously supplied by MDS Analytical Technologies) will be supplied, serviced and supported by Bio-Strategy in both Australia and New Zealand.
Most of MDS Analytical Technologies' Australian employees have joined Bio-Strategy, and instrument warranties and ongoing service agreements have also been transferred to Bio-Strategy.
For any concerns or questions regarding this transition, Bio-Strategy can be contacted on:
Free phone: 1800 00 84 53
Email: info@bio-strategy.com
Web: www.bio-strategy.com
Noxopharm appoints Dr Olivier Laczka CEO
Australian clinical-stage biotech company Noxopharm Limited has appointed Dr Olivier Laczka as...
Nominations now open for the 2026 NMI Measurement Awards
Until 20 May, the National Measurement Institute (NMI) is accepting nominations for the 2026 NMI...
Australia to begin treaty negotiations on association to Horizon Europe
To give Australian organisations access to the world's largest pooled research fund in 2027,...
